INmune Bio Inc. (INMB)
NASDAQ: INMBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 1.85 -0.54%
INMB stock chart
Technical analysisKey statistics
All statistics- Market cap
- $51.62M
- EPS (TTM)
- -$0.67
- Dividend yield
- None
- 52-week range
- 1.09 – 2.60
- Day range
- 1.82 – 1.88
- Volume / Avg
- 104.36K / 416.29K
- Beta
- —
- Shares outstanding
- 27.75M
- Next earnings
- Oct 29, 2026
52-week range
INMB stock today
INmune Bio (INMB) closed at $1.86 on Oct 7, down 0.53% (-$0.01), versus the S&P 500's 0.22% decline. Trading was light, with 104.36K shares changing hands, about 25% of the average daily volume. At this level, INMB sits in the middle of its 52-week range of $1.09 to $2.60: 28.5% below the high, set on Sep 8, 2026 and 70.6% above the low.
INMB is up 19.2% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 5.1%. INmune Bio has posted a net loss over the last twelve months (EPS of -$0.67), so its P/E ratio is not meaningful. The company is scheduled to report Sep/2026 results on Oct 29.
Summary generated from market data by MetaCap's automated system. Methodology
About INmune Bio
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2019
Earnings
Earnings history- Next report
- Oct 29, 2026
INmune Bio peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| EXOZeXoZymes Inc. | 5.54 | -3.15% | $51.55M | vs INMB |
| IMAImageneBio Inc. | 4.61 | -1.91% | $52.43M | vs INMB |
| BKHABlack Hawk Acquisition Corporation Class A | 13.00 | +5.69% | $54.00M | vs INMB |
| LONALeonaBio Inc. | 5.83 | +1.39% | $54.93M | vs INMB |
| TILInstil Bio Inc. | 6.90 | +0.22% | $46.80M | vs INMB |
| INKTMiNK Therapeutics Inc. | 11.42 | -3.47% | $58.28M | vs INMB |
| BSEMBioStem Technologies Inc. | 2.39 | -3.24% | $44.63M | vs INMB |
| ELOXEloxx Pharmaceuticals Inc. | 14.88 | -1.65% | $60.06M | vs INMB |
Indexes, lists and sector
INmune Bio stock FAQ
What is INmune Bio's stock price today?
INMB last traded at $1.86 as of Oct 7, 4:00 PM EDT, down 0.53% on the day. Prices are delayed at least 15 minutes.
When is INmune Bio's next earnings date?
INmune Bio is expected to report earnings on Thursday, October 29, 2026.
What is the INMB 52-week high?
The 52-week high for INMB is $2.60 and the 52-week low is $1.09. The stock is currently 28.5% below its high.